Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Moderna Inc MRNA

Healthcare Biotechnology
Moderna, Inc. is a biotechnology company. The Company is advancing a new class of medicines made of messenger ribonucleic acid (mRNA). It is developing therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases and autoimmune diseases, independently and with its strategic collaborators. mRNA medicines are designed to direct the body’s cells to produce intracellular... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:MRNA)

Moderna Announces Contract with Brazil to Supply 12.5 million COVID-19 Vaccines as Part of National Vaccination Campaign

Accesswire 1 day ago

Moderna to Report First Quarter 2024 Financial Results on Thursday, May 2, 2024

Accesswire 6 days ago

Phase 1/2 Interim Data on Moderna's mRNA-3927, an Investigational mRNA Therapy for Propionic Acidemia, Published in Nature

Accesswire April 3, 2024

Moderna Advances Multiple Vaccine Programs to Late-Stage Clinical Trials

Accesswire March 27, 2024

Moderna Achieves Positive Interim Results from Phase 3 Trial of Next-Generation COVID-19 Vaccine

Accesswire March 26, 2024

Moderna to Host Fifth Annual Investor Event For Vaccines and Business Updates on March 27, 2024

Accesswire February 29, 2024

Moderna to Present at Upcoming Investor Conferences in March 2024

Accesswire February 28, 2024

Moderna Reports Fourth Quarter and Fiscal Year 2023 Financial Results and Provides Business Updates

Accesswire February 22, 2024

Moderna Chief Executive Officer Stéphane Bancel Elected to National Academy of Engineering

Accesswire February 7, 2024
View More News ››

Opinion & Analysis (NDAQ:MRNA)

Memphasys, Moderna, Paion - Investments in solutions with potential

Stockhouse Editorial June 2, 2020

Moderna Shares Rise 25% on Positive Phase 1 Coronavirus Vaccine Trial Data

Streetwise Reports May 19, 2020

BARDA Award Provides 'Lift-off for Biotech's COVID Vaccine'

Streetwise Reports April 23, 2020

U.S.-Based Biotech 'Growing into a Giant with AI'

Streetwise Reports March 9, 2020

Moderna Shares Climb on Development of mRNA Vaccine for Phase 1 Coronavirus Study

Streetwise Reports February 26, 2020

Moderna Shares Rise on the Release of Positive Results from Two mRNA Phase 1 Programs

Streetwise Reports September 13, 2019
View More Opinion ››

Bullboard Posts (NDAQ:MRNA)

Moderna Inc. (NASDAQ: MRNA) Leading the Way in Tuesday Tradi

NEWS: $MRNA Moderna Inc. (NASDAQ: MRNA) Leading the Way in Tuesday Trading Based on Percentage GainModerna, Inc. (NASDAQ: MRNA) is one...
whytestocks - April 9, 2024

Reduce Recommendation Issued On MRNA By HSBC

Just In: $MRNA Reduce Recommendation Issued On MRNA By HSBC2024-02-26 09:15:03 ET HSBC analyst issues REDUCE recommendation for MRNA on...
whytestocks - February 26, 2024

Moderna Stock Is Moving Higher: What's Going On? | Benzinga

JUST IN: $MRNA Moderna Stock Is Moving Higher: What's Going On? | BenzingaModerna@Inc (NASDAQ: MRNA) shares are trading higher...
whytestocks - January 2, 2024

Hurry up....

hThis site just sent me a 68% winner. ttp://stockscreener.tech
rizashakur29 - November 18, 2022

Moderna Shares Soar As Company Announces $3 Billion Stock Bu

Moderna Inc shares on Wednesday soared as high as 17% after it announced that it would be buying back up to US$3 billion of its stock...
AwareInvestor - August 4, 2022

RE:News BioVaxys Confirms First Clinical Site and Principal In

Sounds very promising
Joe455 - May 29, 2022
View more Bullboard ››

Gemina Laboratories Ltd.

Gemina Laboratories Ltd.

Gemina Laboratories Ltd. is a Canada-based biosensor and diagnostic company with a transformative, patented, proprietary ...
View More »